Botanical species · safety record
Kadsura heteroclita
The EFSA Compendium of Botanicals holds 6 constituent measurements for Kadsura heteroclita. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.
Accepted name in source: Kadsura heteroclita (Roxb.) Craib
Regulatory presence
No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.
What the records describe
Constituents measured
- Lignans2
- 1,8-cineole1
- D-epigalbacin1
- Kadsurin1
- Methyleugenol1
Plant parts
- Stem6
- stalk6
Preparations
- Solvent extraction4
- Essential oil2
Recorded constituents
What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.
| Substance | Plant part | Preparation | Concentration | Analytical method | Source |
|---|---|---|---|---|---|
| D-epigalbacin | Stem / stalk | Solvent extraction | ≤ 0.74 Milligram/gram | HPLC-UV | Resolve DOI |
| Lignans | Stem / stalk | Solvent extraction | — | Nuclear Magnetic Resonance (NMR) | Resolve DOI |
| Lignans | Stem / stalk | Solvent extraction | — | Nuclear Magnetic Resonance (NMR) | Resolve DOI |
| 1,8-cineole | Stem / stalk | Essential oil | 3.25 Percent | GC-MS | No resolvable identifier |
| Kadsurin | Stem / stalk | Solvent extraction | — | Unspecified | No resolvable identifier |
| Methyleugenol | Stem / stalk | Essential oil | 1.05 Percent | GC-MS | No resolvable identifier |
Cited sources
The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.
- Wang, W., Liu, JZ., Liu, RX., Xu, ZR., Yang, M., Wang, WX., Liu, P., Sabia, G., Wang, XM., Guo, D. Four new lignans from the stems of Kadsura heteroclita. PLANTA MEDICA, 2006, vol. 72, no. 3, p. 284-288. DOI
- Li, He Qin., Bai, Chun Qi., Chu, Sha Sha., Zhou, Ligang., Du, Shu Shan., Liu, Zhi Long., Liu, Qi Zhi. Chemical composition and toxicities of the essential oil derived from Kadsura heteroclita stems against Sitophilus zeamais and Meloidogyne incognita . Journal of medicinal plants research, 2011, vol. 5, no. 19, p. 4943-4948.
- Chen Min., Luo You-Ping., Zou Yan-Lin., Lang Ling-Hu., Chen Dao-Feng. Heteroclitins R-S: new dibenzocylooctadiene lignans from Kadsura heteroclita. CHINESE JOURNAL OF NATURAL MEDICINES, 2014, vol. 12, no. 9, p. 689-692. DOI
- YANG, XW., HATTORI, M., NAMBA, T., CHEN, DF., XU, GJ. ANTI-LIPID PEROXIDATIVE EFFECT OF AN EXTRACT OF THE STEMS OF KADSURA-HETEROCLITA AND ITS MAJOR CONSTITUENT, KADSURIN, IN MICE. CHEMICAL & PHARMACEUTICAL BULLETIN, 1992, vol. 40, no. 2, p. 406-409.
- Wang, Wei., Liu, Jinzhi., Yang, Min., Sun, Jianghao., Wang, Xiaoming., Liu, Rongxia., Guo, Dean. Simultaneous determination, of six major constituents in the stems of Kadsura heteroclita by LC-DAD. CHROMATOGRAPHIA, 2006, vol. 64, no. 5-6, p. 297-302. DOI
Boundary
A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.
Continue
Europe PMC
Every record indexed for this species, resolvable and re-runnable.
All speciesSubstance index
Search and browse every species this world holds under source and hash.
Before anything elseSafety Centre
Interactions, contraindications and the escalation boundary this world does not cross.
In its own termsTraditions
How the living traditions approach preparation, use and context.